Vaccinology: historical milestones, achievements and problems
DOI:
https://doi.org/10.5281/zenodo.15662465Ключові слова:
Vaccines, history, problems, futureАнотація
Vaccines are immunobiological preparations derived from bacteria, viruses, or their essential products. They are utilized to actively immunize humans and animals to prevent infectious diseases. The extensive application of vaccines facilitates the development of acquired active immunity against corresponding infections, which can cause infectious diseases and pandemic outbreaks. Consequently, in contemporary society, vaccination represents a principal strategy for epidemic prevention. Various technologies are employed in producing safe and highly effective vaccines, including inactivation, attenuation, nucleic acid production, utilization of viral vectors, production of viral subunits, and generation of viral particles. Nonetheless, despite the plethora of available methods, ongoing efforts within the scientific community are concentrated on developing highly competent and effective vaccines that are simultaneously hypoallergenic, immunogenic, and safe. This review article reflects on the historical progression of vaccine development. It elucidates modern vaccine production technologies as human life is safeguarded from various potential diseases, thereby underscoring a significant avenue of research.
Посилання
Rozhko Yuriy. The history of vaccines: from smallpox to COVID-19. URL: https://ingeniusua.org/articles/istoriya-vakcin-vid-naturalnoi-vispi-do-covid-19
Federal Center for Health Education (Germany). URL: www.bzda.de
Robert Koch Institute (Germany). URL: www.rki.de
Paul Ehrlich Institute (Germany). URL: www.pei.de
Standing Commission on Vaccination (Germany). URL: www.stiko.de
Federal Center for Infectious Disease Education (Germany). URL: www.infectionsschutz.de
Eckart von Hirschhausen . The Vaccination Book for Everyone. Berlin: Scholz & Friends , 2021. 82 p.
Vaccinology and Methods in Vaccine Research : Chapter 1 - Immunology and the concept of vaccination / Chukwuanukwu RC, Ehiaghe AF, Rowaiye Oli AN Developments in Immunology. 2022. 30 p.
Klein B. I. Ilya Ilyich Mechnikov (Life and Scientific Activity): monograph. Kyiv, 1947. 30 p.
Mikulina O. I., Bezzubets L. P. Scientific works of I. I. Mechnikov and his Kharkiv students in the collection of the Kharkiv Scientific Medical Library: printed catalog. Kharkiv: Publishing house "Fedorko", 2016. 150 p.
Ehrlich P. On immunity with special reference this cell life . Proceedings of the Royal Society of London . 1900. Vol . 66, R. 424-448
Bering E. , Kitasato S. Über that To get along of diphtheria immunity and tetanus immunity in Tieren . German . Med . Wochenschr . 1890. Vol. 16., P. 1113-1114
Cox HR Use of yolk bag of developing chick embryo as medium for growing . Public Health Rep . 1938. Vol . 53, R. 2241–2247.
Calmette A., Guérin C. Contribution à l'étude from immunity antituberculosis at home bovidés . Ann . Inst . Pasteur . 1914. Vol . 28., R. 329-337.
Ramon G, Zoeller C. (1927) L'anatoxine tetanus and immunization active from the man vis-à-vis the tetanus . Ann Inst Pasteur . 1927. Vol . 41, R. 803–833.
Theiler M, Smith HH The use of yellow fever virus modified by in in vitro cultivation for human immunization . J Exp Med . 1937. Vol . 65, R. 787–808.
Salk JE, Krech U., Younger JS et al . Am.J.Public Health . 1954. Vol . 44. P. 563-570.
Sabin AB, Hennessen WA, Winsser JJ Exp. Med .. 1954. Vol . 99. R. 551-576.
Tizard IR Vaccines for Veterinarians : monograph . Texas Veterinary Medical Center : Texas , USA, 2020. 336 p.
Vaccine Timeline : Historic Dates and Events Related this Vaccines and Immunization https://web.archive.org/web/20160413231652/http://www.immunize.org/timeline/
Karikó K., Ni H., Capodici J., Lamphier M., Weissman D. mRNA is an endogenous ligand for Toll- like receptor . J. Biol . Chem . 2004. 279 (13): 12542—12550.
Karikó K., Buckstein M., Ni H., Weissman D. Suppression of RNA recognition by Toll- like receptors : the impact of nucleoside modification and the evolutionary origin of RNA. Immunity . 2005. 23(2): 165—175.
Karikó K., Muramatsu H., Welsh FA, Ludwig J., Kato H., Akira S., Weissman D. Incorporation of pseudouridine into mRNA yields superior non-immunogenic vector with increased translational capacity and biological stability . Mol . Ther . 2008. 16(11): 1833—1840.
World Health Organization (WHO). URL: https://www.who.int/eng/health-topics/vaccines-and-immunization#tab=tab_1
Chernyshova L.I., Lapiy F.I. Modern technologies of vaccine production. Child's health. 2014. No. 4 (55). P. 167-171
Information and analytical search for innovative methods of virus inactivation: Innovative ways of improving medicine , psychology and biology : collective monograph / Kalinichenko S.V. and others Boston : Primedia eLaunch , 2023. 305 https://doi.org/10.46299/ISG.2023.MONO.MED.2
Dubinina N., Tishchenko I., Kosova O., Kalinichenko S., Samadov B. Vaccines for HIV prevention : achievements and perspectives . Norwegian Journal of development of the International Science . Oslo , Norway , 2023. No. 110. R. 25-28. https://nor-ijournal.com/wp-content/uploads/2023/09/NJD_110.pdf
Public Health Center. Immunization. URL: https://phc.org.ua/kontrol-zakhvoryuvan/imunizaciya/zagalna-informaciya
National Immunization Portal. Vaccination Library. URL: https://vaccine.org.ua/pro-vakczynacziyu/about-vaccination-library/
State Expert Center of the Ministry of Health of Ukraine. Types of vaccines and their development. Vaccination as the most effective method of protecting the population from infectious diseases. URL: https://www.dec.gov.ua/wp-content/uploads/Conference/2020/6/section/9/s9f3.pdf
Coughlan, L., Kremer, E. J., & Shayakhmetov, D. M. (2022). Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens. Molecular Therapy, 30(5), 1822-1849. DOI: 10.1016/j.ymthe.2022.01.034
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2025 Анали Мечниковського Інституту

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.